Detalhe da pesquisa
1.
Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.
PLoS Med
; 15(9): e1002660, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30248105
2.
European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease-the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow.
BMJ Open
; 6(7): e011584, 2016 07 19.
Artigo
Inglês
| MEDLINE | ID: mdl-27436668
3.
NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease.
BMJ Open
; 4(10): e006364, 2014 Oct 09.
Artigo
Inglês
| MEDLINE | ID: mdl-25300460